David Cortez
Faculty Member
Last active: 2/4/2016

  1. ATR and ATRIP: partners in checkpoint signaling. Cortez D, Guntuku S, Qin J, Elledge SJ (2001) Science 294(5547): 1713-6
    › Primary publication · 11721054 (PubMed)
  2. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Tibbetts RS, Cortez D, Brumbaugh KM, Scully R, Livingston D, Elledge SJ, Abraham RT (2000) Genes Dev 14(23): 2989-3002
    › Primary publication · 11114888 (PubMed) · PMC317107 (PubMed Central)
  3. Conducting the mitotic symphony. Cortez D, Elledge SJ (2000) Nature 406(6794): 354-6
    › Primary publication · 10935617 (PubMed)
  4. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K, Luo G, Carattini-Rivera S, DeMayo F, Bradley A, Donehower LA, Elledge SJ (2000) Genes Dev 14(12): 1448-59
    › Primary publication · 10859164 (PubMed) · PMC316686 (PubMed Central)
  5. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J (2000) Genes Dev 14(8): 927-39
    › Primary publication · 10783165 (PubMed) · PMC316544 (PubMed Central)
  6. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Cortez D, Wang Y, Qin J, Elledge SJ (1999) Science 286(5442): 1162-6
    › Primary publication · 10550055 (PubMed)
  7. The univector plasmid-fusion system, a method for rapid construction of recombinant DNA without restriction enzymes. Liu Q, Li MZ, Leibham D, Cortez D, Elledge SJ (1998) Curr Biol 8(24): 1300-9
    › Primary publication · 9843682 (PubMed)
  8. Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway. Dai Z, Quackenbush RC, Courtney KD, Grove M, Cortez D, Reuther GW, Pendergast AM (1998) Genes Dev 12(10): 1415-24
    › Primary publication · 9585502 (PubMed) · PMC316832 (PubMed Central)
  9. A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation. Reuther JY, Reuther GW, Cortez D, Pendergast AM, Baldwin AS (1998) Genes Dev 12(7): 968-81
    › Primary publication · 9531535 (PubMed) · PMC316671 (PubMed Central)
  10. The Bcr-Abl tyrosine kinase activates mitogenic signaling pathways and stimulates G1-to-S phase transition in hematopoietic cells. Cortez D, Reuther G, Pendergast AM (1997) Oncogene 15(19): 2333-42
    › Primary publication · 9393877 (PubMed)